GlaxoSmithKline S.A.E (EGX:BIOC)

GlaxoSmithKline S.A.E Balance Sheet

Financials in millions EGP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	342.82	75.47	829.34	585.85	73.57	22.16
Cash & Short-Term Investments	342.82	75.47	829.34	585.85	73.57	22.16
Cash Growth	61.54%	-90.90%	41.56%	696.36%	232.01%	-91.18%
Accounts Receivable	614.48	619.73	685.96	424.68	253.94	269.39
Other Receivables	28.21	50.34	23.89	318.64	408.81	221.5
Receivables	1,647	1,661	1,176	1,165	830.42	641.44
Inventory	1,573	945.21	695.27	485.89	500.45	456.05
Prepaid Expenses	-	-	-	-	17.58	20.46
Other Current Assets	157.91	183.55	164.7	216.65	126.47	143.34
Total Current Assets	3,721	2,865	2,866	2,454	1,548	1,283
Property, Plant & Equipment	684.12	641.17	572.14	548.11	540.21	476.53
Long-Term Investments	-	7.34	6.34	24.45	12.3	21.51
Goodwill	-	-	-	137.65	238.65	238.65
Long-Term Deferred Tax Assets	-	23.33	17.43	-	-	-
Other Long-Term Assets	125.67	115.83	96.48	21.33	85.09	97.2
Total Assets	4,531	3,653	3,558	3,185	2,425	2,117
Accounts Payable	177.49	486.93	524.53	176.8	104.54	49.28
Accrued Expenses	593.2	577.83	524.12	304.51	581.22	522.35
Short-Term Debt	1,184	-	-	-	118.21	145.73
Current Portion of Leases	43.96	38.28	28.39	17.48	29.52	-
Current Income Taxes Payable	37.81	159.39	97.93	308.57	17.38	1.23
Other Current Liabilities	392.41	313.45	348.98	585.89	161.22	170.56
Total Current Liabilities	2,429	1,576	1,524	1,393	1,012	889.15
Long-Term Leases	36.24	81.2	68.63	52.07	32.24	-
Long-Term Deferred Tax Liabilities	30.99	-	-	11.31	22.46	15.09
Total Liabilities	2,497	1,657	1,593	1,457	1,067	904.25
Common Stock	835.14	835.14	835.14	835.14	835.14	835.14
Retained Earnings	1,199	1,160	1,130	892.71	522.24	377.36
Total Common Equity	2,034	1,995	1,965	1,728	1,357	1,213
Minority Interest	0.61	0.6	0.6	0.58	0.58	0.59
Shareholders' Equity	2,034	1,996	1,965	1,728	1,358	1,213
Total Liabilities & Equity	4,531	3,653	3,558	3,185	2,425	2,117
Total Debt	1,265	119.48	97.03	69.55	179.97	145.73
Net Cash (Debt)	-921.85	-44.01	732.32	516.3	-106.41	-123.58
Net Cash Growth	-	-	41.84%	-	-	-
Net Cash Per Share	-10.98	-0.53	8.77	6.18	-1.27	-1.48
Filing Date Shares Outstanding	83.51	83.51	83.51	83.51	83.51	83.51
Total Common Shares Outstanding	83.51	83.51	83.51	83.51	83.51	83.51
Working Capital	1,292	1,289	1,342	1,060	536.41	394.3
Book Value Per Share	24.35	23.89	23.53	20.69	16.25	14.52
Tangible Book Value	2,034	1,995	1,965	1,590	1,119	973.85
Tangible Book Value Per Share	24.35	23.89	23.53	19.04	13.40	11.66
Land	-	17.59	17.59	12.65	12.65	12.65
Buildings	-	74.34	83.47	97.81	97.81	97.81
Machinery	-	696.44	668.83	662.18	629.59	571.91
Construction In Progress	136.76	152.54	108.51	88.86	98.67	122.98
Leasehold Improvements	-	24.27	26.81	26.85	42.34	42.34

Source: S&P Global Market Intelligence. Standard template. Financial Sources.